Definitive Healthcare DH Income Statement (2020-2026)

NASDAQ DH
$1.05 +0.01 (+0.96%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

Definitive Healthcare Quarterly Income Statement

Periods 26 quarters
Latest Jun 2026

Definitive Healthcare reported revenue of $55.20M and net income of -$7.45M for the quarter ended Jun 2026, down 9.1% year over year. This income statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
43.08M46.31M50.12M54.55M57.38M60.60M59.20M60.96M65.33M65.93M63.48M63.74M62.70M62.29M59.19M60.75M60.05M61.53M55.93M55.20M
Cost of RevenueCost of Rev
5.13M5.53M5.95M6.20M6.57M7.15M8.55M8.08M8.66M22.19M13.10M13.28M13.67M14.69M15.43M14.14M14.05M14.62M14.28M14.65M
Gross Profit
32.60M35.41M38.80M42.77M47.66M50.80M47.30M49.79M53.43M53.42M50.38M50.45M49.03M47.60M43.76M46.61M45.99M46.91M41.65M40.54M
Operating items
Amortization - Intangibles
5.36M5.37M5.38M5.58M3.15M2.65M3.35M3.09M3.23M3.07M3.36M3.38M3.59M3.72M5.29M5.34M4.98M4.68M4.92M5.24M
Research & DevelopmentR&D
14.38M17.38M21.29M23.59M21.18M23.52M23.42M24.70M22.80M23.61M21.76M21.55M20.13M20.37M20.65M20.47M20.38M20.14M19.58M19.16M
Selling, General & AdministrativeSG&A
8.50M12.56M11.04M10.06M14.35M16.12M14.08M13.67M14.54M16.57M16.88M12.53M11.35M8.50M12.27M12.67M12.36M14.32M12.08M10.81M
Restructuring CostsRestructuring
-0.14M2.96M1.31M2.11M2.94M1.53M2.59M3.57M3.50M1.83M8.53M2.90M-2.00M2.83M1.30M0.70M5.31M0.38M-0.77M2.03M
Other Operating ExpensesOther Opex
14.51M15.61M16.72M18.90M19.24M20.17M19.47M19.92M307.95M21.49M19.45M383.12M244.91M115.47M194.32M16.94M16.63M38.70M212.04M15.30M
Operating ExpensesOpex
37.24M48.51M50.36M54.65M57.72M61.34M59.57M61.86M348.81M63.50M66.63M420.10M274.40M147.16M228.55M50.78M54.68M73.54M242.94M47.29M
Operating IncomeOp. Inc
-4.64M-13.10M-11.57M-11.88M-10.06M-10.54M-12.27M-12.07M-295.38M-10.08M-16.25M-369.64M-225.37M-99.56M-184.79M-4.17M-8.69M-26.63M-201.29M-6.75M
EBIT
-4.64M-13.10M-11.57M-11.88M-10.06M-10.54M-12.27M-12.07M-295.38M-10.08M-16.25M-369.64M-225.37M-99.56M-184.79M-4.17M-8.69M-26.63M-201.29M-6.75M
Non-operating items
Non Operating Interest Expenses
7.19M1.92M1.95M2.76M3.07M1.48M3.61M3.79M3.90M3.90M3.82M3.80M3.75M3.51M2.43M3.00M3.00M2.88M2.63M2.63M
Interest & Investment IncomeInt & Inv Inc
0.07M0.18M0.61M1.93M2.83M3.57M3.46M3.77M3.93M3.72M3.74M3.20M2.10M1.75M1.70M1.50M1.30M1.30M
Other Non Operating IncomeOther Non Op Inc.
-16.94M-1.76M-1.90M4.10M5.63M0.86M-4.41M-1.02M29.16M-2.11M2.75M41.55M23.82M8.95M18.81M-4.64M-8.58M9.43M5.50M-1.05M
Net income details
EBT
-21.58M-14.86M-13.46M-10.36M-6.90M-11.16M-16.68M-13.09M-266.22M-12.19M-13.50M-328.09M-201.55M-90.61M-165.98M-8.81M-17.27M-17.20M-195.79M-7.80M
Tax ProvisionsTaxes
-0.21M0.24M-0.43M-0.21M-0.01M-17.04M-0.71M-1.48M-17.53M1.18M-0.78M-21.90M-13.72M-5.89M-10.89M0.46M0.52M-34.04M-3.44M-0.34M
Profit After TaxPAT
-21.37M-15.11M-13.04M-10.14M-6.88M9.87M-15.97M-11.61M-248.69M-13.36M-12.72M-306.19M-187.82M-84.72M-155.09M-9.27M-17.79M-17.15M-192.35M-7.45M
Income from Non-Controlling InterestsInc. Minority
-5.17M-5.24M-4.46M-4.66M-3.87M-3.98M-3.91M-3.04M-77.16M-3.13M-3.20M-92.55M-56.93M-25.64M-47.87M-1.71M-2.95M-7.83M-53.73M-2.03M
Income from Continuing OperationsIncome (Continuing)
-21.37M-15.11M-13.04M-10.14M-6.88M5.89M-15.97M-11.61M-248.69M-13.36M-12.72M-306.19M-187.82M-84.72M-155.09M-9.27M-17.79M16.84M-192.35M-7.45M
Consolidated Net IncomeConsol Net Inc.
-21.37M-15.11M-13.04M-10.14M-6.88M5.89M-15.97M-11.61M-248.69M-13.36M-12.72M-306.19M-187.82M-84.72M-155.09M-9.27M-17.79M16.84M-192.35M-7.45M
Income towards Parent CompanyParent Net Inc
-21.37M-15.11M-13.04M-10.14M-6.88M5.89M-15.97M-11.61M-248.69M-13.36M-12.72M-306.19M-187.82M-84.72M-155.09M-9.27M-17.79M16.84M-192.35M-7.45M
Net Income towards Common StockholdersNet Income
-21.37M-15.11M-13.04M-10.14M-6.88M5.89M-15.97M-11.61M-248.69M-13.36M-12.72M-306.19M-187.82M-84.72M-155.09M-9.27M-17.79M16.84M-192.35M-7.45M
Additional items
EPS (Basic)
-0.24-0.16-0.13-0.10-0.070.06-0.15-0.10-2.17-0.12-0.11-2.60-1.61-0.73-1.38-0.09-0.170.16-1.84-0.07
EPS (Diluted)
-0.24-0.16-0.13-0.10-0.070.06-0.15-0.10-2.17-0.12-0.11-2.60-1.61-0.73-1.38-0.09-0.170.16-1.84-0.07
Shares Outstanding
88.26M91.92M97.16M99.20M102.90M101.11M108.23M111.77M114.53M112.76M117.43M117.75M116.38M116.64M112.78M106.82M103.78M106.65M104.68M105.81M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
88.26M91.92M97.16M99.20M102.90M101.11M108.23M111.77M114.53M112.76M117.43M117.75M116.38M116.64M112.78M106.82M103.78M106.65M104.68M105.81M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
145.48M152.52M152.61M152.68M105.08M107.60M154.38M113.30M155.41M155.73M157.03M117.12M115.52M153.33M153.33M143.14M142.36M142.36M105.52M106.74M
EBITDA
-4.64M-13.10M-11.57M-11.88M-10.06M-10.54M-12.27M-12.07M-295.38M-10.08M-16.25M-369.64M-225.37M-99.56M-184.79M-4.17M-8.69M-26.63M-201.29M-6.75M
Interest ExpensesInt Expense
7.19M1.92M1.95M2.76M3.07M1.48M3.61M3.79M3.90M3.90M3.82M3.80M3.75M3.51M2.43M3.00M3.00M2.88M2.63M2.63M
Tax Rate
0.98%-1.65%3.16%2.06%0.22%152.77%4.26%11.34%6.59%-9.64%5.78%6.68%6.81%6.51%6.56%-5.18%-3.03%197.89%1.75%4.42%